《公司業績》金界控股(03918.HK)半年盈轉虧蝕7,722.9萬美元
金界控股(03918.HK)公布截至今年6月底止中期業績,營業額1.3億美元(下同),按年跌65.4%。盈轉虧蝕7,722.9萬元,上年同期賺2,062.6萬元;每股虧損1.78仙。不派息。
期內,博彩收入為1.29億美元,EBITDA為1,120萬元,經調整EBITDA為1,770萬元。
公司指,業績反映了自2021年3月2日開始為應對柬埔寨爆發新型冠狀病毒而自願暫停業務營運所產生的影響,令上半年業務營運實際只有兩個月。自自願暫停業務營運以來,集團已採取一系列措施盡量減低所需營運成本及現金支出。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.